A Multicenter Study to Evaluate the Cios Spin and the Ion Endoluminal System for Pulmonary Nodule Biopsy
The overall objective of this study is to evaluate procedure characteristics of pulmonary nodule biopsies using the integrated version of Cios Spin and the Ion Endoluminal System.
Checked against the public recordLast updated Nov 13, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Intuitive Surgical
- Interventions being studied
- Device: Ion Endoluminal System and Cios Spin
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Subject is 18 years or older at the time of the procedure. * Pulmonary nodule biopsy attempted/performed using the Ion Endoluminal System and Cios Spin 3D imaging. * Pulmonary nodule ≤2 cm in largest diameter. * Subject able to understand and adhere to study requirements and provide informed consent. Exclusion Criteria: * Planned lymph node staging performed before nodule biopsy. * Nodule is a pure ground glass opacity. * Plan to biopsy multiple nodules.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of Alabama at BirminghamBirmingham, Alabama
- University of California San Diego, Hillcrest Medical CenterSan Diego, California
- Mayo Clinic - RochesterRochester, Minnesota
- Memorial Sloan Kettering Cancer CenterNew York, New York
- South Austin HospitalAustin, Texas
- MD Anderson Cancer CenterHouston, Texas
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 13, 2025. Always confirm current availability with the study team.